Late-Stage Study of Merck & Co.’s Keytruda Shows Promising Results for Bladder Cancer Patients
A recent Phase 3 study conducted by Merck & Co. has demonstrated positive outcomes for patients with an advanced form of bladder cancer who were treated with Keytruda, the company's…